Search

Author/Creator Bonomi, Philip

1. Bioinformatics Model of Serum Biomarkers to Prognosticate the Response to Programmed Death-1/Ligand-1 Targeted Immunotherapy in Metastatic Non–Small Cell Lung Cancer. (11th September 2019)

Authors:
Tarhoni, Imad; Multani, Maneet; Fughhi, Ibtihaj; Gerard, David; Fidler, Mary; Batus, Marta; Bonomi, Philip; Borgia, Jeffrey
Journal:
American journal of clinical pathology
Issue:
Volume 152(2019)Supplement 1
Page Start:
S137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Clinicopathologic Features of Advanced Squamous NSCLC. Issue 9 (September 2016)

Authors:
Socinski, Mark A.; Obasaju, Coleman; Gandara, David; Hirsch, Fred R.; Bonomi, Philip; Bunn, Paul; Kim, Edward S.; Langer, Corey J.; Natale, Ronald B.; Novello, Silvia; Paz‐Ares, Luis; Pérol, Maurice; Reck, Martin; Ramalingam, Suresh S.; Reynolds, Craig H.; Spigel, David R.; Stinchcombe, Thomas E....
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 9(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment. Issue 12 (December 2016)

Authors:
Langer, Corey J.; Obasaju, Coleman; Bunn, Paul; Bonomi, Philip; Gandara, David; Hirsch, Fred R.; Kim, Edward S.; Natale, Ronald B.; Novello, Silvia; Paz‐Ares, Luis; Pérol, Maurice; Reck, Martin; Ramalingam, Suresh S.; Reynolds, Craig H.; Socinski, Mark A.; Spigel, David R.; Wakelee, Heather; Mayo...
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 12(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Phase 2, randomized, open‐label study of ramucirumab in combination with first‐line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non–small cell lung cancer. Issue 6 (6th November 2014)

Authors:
Doebele, Robert C.; Spigel, David; Tehfe, Mustapha; Thomas, Sachdev; Reck, Martin; Verma, Sunil; Eakle, Janice; Bustin, Frederique; Goldschmidt, Jerome; Cao, Dachuang; Alexandris, Ekaterine; Yurasov, Sergey; Camidge, D. Ross; Bonomi, Philip
Journal:
Cancer
Issue:
Volume 121:Issue 6(2015)
Page Start:
883
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer. Issue 2 (February 2015)

Authors:
Spigel, David R.; Patel, Jyoti D.; Reynolds, Craig H.; Garon, Edward B.; Hermann, Robert C.; Govindan, Ramaswamy; Olsen, Mark R.; Winfree, Katherine B.; Chen, Jian; Liu, Jingyi; Guba, Susan C.; Socinski, Mark A.; Bonomi, Philip
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 2(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer. Issue 2 (February 2015)

Authors:
Spigel, David R.; Patel, Jyoti D.; Reynolds, Craig H.; Garon, Edward B.; Hermann, Robert C.; Govindan, Ramaswamy; Olsen, Mark R.; Winfree, Katherine B.; Chen, Jian; Liu, Jingyi; Guba, Susan C.; Socinski, Mark A.; Bonomi, Philip
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 2(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗